Lowering urban density to protect against the coronavirus would be a misguided response. Density is not a key driver of infection, and keeps people active and healthy.
Currently, there is no evidence that this highly effective antimalarial can treat COVID-19 – and the threat of drug resistance should deter us from using it indiscriminately.
Angharad Davies, Swansea University; Andrew Lee, University of Sheffield; Jimmy Whitworth, London School of Hygiene & Tropical Medicine, and Lakshmi Manoharan, University of Oxford
New Zealand has managed it, but densely populated, highly infected countries face a bigger challenge.
Testing healthcare workers can play a role in preventing new infections, but is a highly limited strategy and shouldn’t distract from other, more helpful measures.
The virus that caused the original Sars no longer haunts us, but the characteristics of today’s coronavirus mean it’s unlikely to disappear in the same way.
A continuous lock down is detrimental to Nigeria’s large population of people living below poverty lines, but lifting the restrictions without a proper plan is equally dangerous. Here’s what to do.
Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections, and Professor of Neurology, University of Liverpool